SaaT System - Market Brief

SaaT System is a Smart AI Analytics Trading System, a cutting-edge platform designed to provide in-depth analysis and insights into the financial markets, powered by advanced AI technologies. The SaaT platform data is provided for informational purposes only. It should not be considered financial or legal advice.

SPY (S&P 500)

SPY is $659.89, up $0.03 (0.00%) on 2025-09-16. Compared to previous day close, down 0.15%. Volume: 1,016,087

QQQ (Nasdaq)

QQQ is $591.14, down $0.26 (-0.04%) on 2025-09-16. Compared to previous day close, down 0.09%. Volume: 629,209

DIA (Dow Jones)

DIA is $458.26, down $0.04 (-0.01%) on 2025-09-16. Compared to previous day close, down 0.39%. Volume: 111,921

BTC (Bitcoin)

Bitcoin is $115,213.61, down $89.31 (-0.08%) on 2025-09-16. Compared to previous day close, down 0.15%. Volume: 122.15 BTC

Top Daily Gainers

Company Last Price Change %
CHEK 2.12 185.83%
HSDT 18.27 141.67%
ATCH 0.94 141.03%
MTVA 1.50 115.55%
IHT 3.40 70.00%
NAOV 10.70 64.87%

Top Daily Losers

Company Last Price Change %
ATYR 1.02 -83.17%
SHOTW 0.02 -66.67%
NAKA 1.24 -55.40%
ALDFW 0.25 -54.53%
SCLXW 0.20 -49.75%
WLDSW 2.50 -46.81%

Most Active Stocks

Company Last Price Change %
CHEK 2.12 185.83%
ATCH 0.94 141.03%
OPI 0.88 59.62%
BIAF 0.35 29.78%
WOLF 2.96 27.04%
GPUS 0.45 21.62%

MGPI ALERT: Bragar Eagel & Squire, P.C. is Investigating MGP Ingredients, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - MGP Ingredients ( NASDAQ:MGPI )

Publish date: 2025-09-16

Symbol: META

Source: Benzinga

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In MGP Ingredients ( MGPI ) To Contact Him Directly To Discuss Their Options

Draganfly and Autonome to Highlight Landmine Route Clearance Technology at Countering Explosives Conference

Publish date: 2025-09-16

Symbol: DPRO

Source: GlobeNewswire

Tampa, FL, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Draganfly Inc. ( NASDAQ: DPRO. CSE: DPRO. FSE: 3U8 ) ( "Draganfly" or the "Company" ) , an award-winning, industry-leading drone solutions and systems developer, announced it will attend the upcoming Countering Explosives Conference hosted by ...

Trump Media's CRO Strategy SPAC Deal Could Redefine Digital Asset Treasuries - ( YORK ) , Trump Media & Tech Gr ( NASDAQ:DJT )

Publish date: 2025-09-16

Symbol: MCGA

Source: Benzinga

Trump Media & Technology Group DJT, Yorkville Acquisition Corp. YORK, and Crypto.com have announced plans to create Trump Media Group CRO Strategy, Inc., a new company structured as a digital asset treasury.

Buying IDEAYA Might Be The Wrong IDYA Right Now - IDEAYA Biosciences ( NASDAQ:IDYA )

Publish date: 2025-09-16

Symbol: IDYA

Source: Benzinga

IDEAYA Biosciences IDYA is currently in Phase 8 of its 18-phase Adhishthana cycle on the weekly charts. Under the lens of the Adhishthana Principles, the stock's outlook appears weak, with signs suggesting it may remain range-bound and underperform until May 2029.

Aduro Clean Technologies Europe Joins Dutch Trade Delegation at Expo 2025 Osaka Japan - Aduro Clean Technologies ( NASDAQ:ADUR )

Publish date: 2025-09-16

Symbol:

Source: Benzinga

LONDON, Ontario, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Aduro Clean Technologies Inc. ( "Aduro" or the "Company" ) ADUR ( CSE: ACT ) 9D5, a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into ...

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Publish date: 2025-09-16

Symbol: BNGO

Source: GlobeNewswire

SAN DIEGO, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Bionano Genomics, Inc. ( Nasdaq: BNGO ) today announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement known as chromoanagenesis was published with multiple studies ...

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes ( T2D ) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update - Biomea Fusion ( NASDAQ:BMEA )

Publish date: 2025-09-16

Symbol: BMEA

Source: Benzinga

In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given semaglutide alone. U.S.

Focal One® HIFU Receives Prestigious Innovation Award

Publish date: 2025-09-16

Symbol: EDAP

Source: GlobeNewswire

AUSTIN, Texas, September 16, 2025 - EDAP TMS SA ( Nasdaq: EDAP ) , the global leader in robotic energy-based therapies, announced today that the company has been honored with the 2025 Industry Award for Innovations in Endourological Instrumentation by the Endourological Society in recognition of ...

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635 ( c ) ( 4 )

Publish date: 2025-09-16

Symbol: EYPT

Source: GlobeNewswire

WATERTOWN, Mass., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc. ( Nasdaq: EYPT ) , a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory ...

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States - Harvard Bioscience ( NASDAQ:HBIO )

Publish date: 2025-09-16

Symbol: HBIO

Source: Benzinga

HOLLISTON, Mass., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Harvard Bioscience, Inc.

© - SaaT System